Literature DB >> 9158140

Homozygous alpha6 integrin mutation in junctional epidermolysis bullosa with congenital duodenal atresia.

L Pulkkinen1, V E Kimonis, Y Xu, E N Spanou, W H McLean, J Uitto.   

Abstract

Junctional epidermolysis bullosa with congenital pyloric or duodenal atresia is a distinct variant within this group of autosomal recessive blistering skin diseases. In this study we demonstrate, for the first time, a homozygous mutation in the alpha6 integrin gene (ITGA6) in a family with three affected individuals. For this purpose, we first determined the genomic organization of ITGA6, and placed the gene on chromosome 2q by high resolution radiation hybrid mapping. Heteroduplex analysis of PCR products containing the individual exons of ITGA6, followed by direct nucleotide sequencing, revealed that the proband was homozygous for a G-to-T transversion in the +1 position of intron 12. This mutation, 1856+1G-->T, affects an invariant base of the 5' donor splice site predicting aberrant splicing involving exon 12. The mutation was verified in the proband's DNA by restriction enzyme digestion which also confirmed that the parents were heterozygous carriers of this mutation. Altered expression of alpha6 integrin, which forms a heterodimer with the beta4 subunit at the dermal-epidermal junction, would explain fragility and blistering as a result of minor trauma to the skin.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9158140     DOI: 10.1093/hmg/6.5.669

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  18 in total

1.  α6β4 integrin, a master regulator of expression of integrins in human keratinocytes.

Authors:  Kristina R Kligys; Yvonne Wu; Susan B Hopkinson; Surinder Kaur; Leonidas C Platanias; Jonathan C R Jones
Journal:  J Biol Chem       Date:  2012-04-06       Impact factor: 5.157

2.  First successful preimplantation genetic diagnosis of epidermolysis bullosa with pyloric atresia: case study of a novel c.4505-4508insACTC mutation.

Authors:  Ayvaz Ozge; Hatırnaz Safak; Hatırnaz Ebru; Unsal Evrim; Sinanoglu Ekin Bilge; Ozer Leyla; Kadı Ali Kemal; Baltacı Volkan
Journal:  J Assist Reprod Genet       Date:  2012-02-22       Impact factor: 3.412

3.  α6-Integrin is required for the adhesion and vasculogenic potential of hemangioma stem cells.

Authors:  David M Smadja; Coralie L Guerin; Elisa Boscolo; Ivan Bieche; John B Mulliken; Joyce Bischoff
Journal:  Stem Cells       Date:  2014-03       Impact factor: 6.277

Review 4.  Diseases of epidermal keratins and their linker proteins.

Authors:  Jouni Uitto; Gabriele Richard; John A McGrath
Journal:  Exp Cell Res       Date:  2007-04-24       Impact factor: 3.905

5.  Epidermolysis bullosa. I. Molecular genetics of the junctional and hemidesmosomal variants.

Authors:  R Varki; S Sadowski; E Pfendner; J Uitto
Journal:  J Med Genet       Date:  2006-02-10       Impact factor: 6.318

Review 6.  The role of laminins in basement membrane function.

Authors:  M Aumailley; N Smyth
Journal:  J Anat       Date:  1998-07       Impact factor: 2.610

7.  Epidermolysis bullosa with pyloric atresia: novel mutations in the beta4 integrin gene (ITGB4).

Authors:  L Pulkkinen; D U Kim; J Uitto
Journal:  Am J Pathol       Date:  1998-01       Impact factor: 4.307

8.  Platelet integrin α6β1 controls lung metastasis through direct binding to cancer cell-derived ADAM9.

Authors:  Elmina Mammadova-Bach; Paola Zigrino; Camille Brucker; Catherine Bourdon; Monique Freund; Adèle De Arcangelis; Scott I Abrams; Gertaud Orend; Christian Gachet; Pierre Henri Mangin
Journal:  JCI Insight       Date:  2016-09-08

9.  Novel ITGB4 mutations in lethal and nonlethal variants of epidermolysis bullosa with pyloric atresia: missense versus nonsense.

Authors:  L Pulkkinen; F Rouan; L Bruckner-Tuderman; R Wallerstein; M Garzon; T Brown; L Smith; W Carter; J Uitto
Journal:  Am J Hum Genet       Date:  1998-11       Impact factor: 11.025

Review 10.  Epidermolysis bullosa with pyloric atresia.

Authors:  Hye Jin Chung; Jouni Uitto
Journal:  Dermatol Clin       Date:  2010-01       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.